Cipher Pharmaceuticals is a growing specialty pharmaceutical dermatology company, with a robust and diversified portfolio of commercial and early to late-stage products. Through multiple transactions, Cipher has built its U.S. commercial presence, expanded its Canadian dermatology franchise and broadened its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution.
CIPHER PHARMACEUTICALS ANNOUNCES PLANS TO VOLUNTARILY DELIST FROM NASDAQ
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Receive E-mail Alerts|
|Sign up to receive e-mail alerts whenever Cipher Pharmaceuticals Inc posts new information to the site. Just enter your e-mail address and click Submit.|